ADVANCED OR METASTATIC SOLID TUMOR
Clinical trials for ADVANCED OR METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill combo takes aim at Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests an experimental oral drug called GSK4524101, either alone or combined with another drug (niraparib), in adults with advanced solid tumors that have stopped responding to standard treatments. The study has two parts: first, finding a safe dose, and sec…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug aims to boost immune system against advanced cancers
Disease control OngoingThis early-stage study tests a new drug called IOA-244 in about 210 adults with advanced or metastatic cancers like lung cancer, melanoma, and lymphoma. The main goal is to see if the drug is safe and tolerable, both alone and combined with other treatments. Researchers also chec…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: iOnctura • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug ASKB589 tested against advanced cancers
Disease control OngoingThis study tests an experimental drug called ASKB589 in about 199 people with advanced solid tumors that have spread. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. People with stomach or pancreatic cancer are especially wanted for …
Matched conditions: ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:35 UTC
-
New pill shows promise against Hard-to-Treat cancers
Disease control OngoingThis study tests an experimental oral drug called IMM-1-104, which blocks certain cancer-driving proteins. It is given alone or with standard chemotherapy to people with advanced solid tumors that have RAS mutations, including pancreatic, melanoma, and lung cancers. The trial aim…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Immuneering Corporation • Aim: Disease control
Last updated Jun 26, 2026 12:32 UTC